{
    "organizations": [],
    "uuid": "5ca2d45b630b1e693537b2618162317055c42a57",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-oncolytics-biotech-announces-colla/brief-oncolytics-biotech-announces-collaboration-with-merck-and-northwestern-university-idUSFWN1SO0IA",
    "ord_in_thread": 0,
    "title": "BRIEF-Oncolytics Biotech速 Announces Collaboration With Merck And Northwestern University",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 17 (Reuters) - Oncolytics Biotech Inc:\n* ONCOLYTICS BIOTECH速 ANNOUNCES COLLABORATION WITH MERCK AND NORTHWESTERN UNIVERSITY COMBINING KEYTRUDA速 AND REOLYSIN速 IN A PHASE 2 SECOND LINE PANCREATIC CANCER STUDY Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-05-17T19:13:00.000+03:00",
    "crawled": "2018-05-18T19:40:12.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "oncolytics",
        "biotech",
        "inc",
        "oncolytics",
        "announces",
        "collaboration",
        "merck",
        "northwestern",
        "university",
        "combining",
        "phase",
        "second",
        "line",
        "pancreatic",
        "cancer",
        "study",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}